This inventor holds 2 USPTO granted patents. Top assignee: University of Kansas. Active years: 2019-2021.
Location History:
- Lawrence, KS (US) (2019)
- Marion, OH (US) (2021)
Company Filing History:
Years Active: 2019-2021
Title: Innovations by Alex Christopher Salyer
Introduction
Alex Christopher Salyer is an accomplished inventor based in Lawrence, KS (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of toll-like receptor modulators. With a total of 2 patents, Salyer is recognized for his innovative approaches to therapeutic compounds.
Latest Patents
Salyer's latest patents include "Human TLR8-selective agonists" and "Toll-like receptor agonists." The first patent discloses human toll-like receptor modulators of general Formula (II), wherein specific components are defined. The second patent describes compounds that can be utilized for therapeutic purposes, specifically as TLR agonists, such as TLR7 or TLR8 agonists. These compounds can be incorporated into pharmaceutical compositions and are useful in various therapies. The patents detail the potential of these compounds to serve as adjuvants in vaccines and other therapeutic applications.
Career Highlights
Salyer is affiliated with the University of Kansas Medical Center Research Institute, where he conducts research and develops innovative solutions in the pharmaceutical field. His work focuses on creating compounds that can enhance immune responses and improve therapeutic outcomes.
Collaborations
Some of Salyer's notable coworkers include Sunil Abraham David and Mallesh Beesu. Their collaborative efforts contribute to the advancement of research in the field of immunology and pharmaceutical sciences.
Conclusion
Alex Christopher Salyer is a notable inventor whose work in toll-like receptor modulators has the potential to impact therapeutic practices significantly. His contributions to the field are marked by his innovative patents and collaborative research efforts.